O'Brien, D., Chunduri, P., Iyer, A., and Brown, L
Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review." ( Clinical Endocrinology , 2026)
It was nuts I could not believe it. - Wegovy patient This CNN article has a story that really articulates the immediacy and unexpected nature of the positive impact for many: A smoker for most of her life, Ferguson started Ozempic 11 weeks ago to try to lose about 50 pounds shed gained during the Covid-19 pandemic, which had made her prediabetic
The benefits of GLP-1 receptor agonists likely extend beyond weight loss alone, Patel told Healio
Tier 2: advanced alternatives in late-stage development These medications are not yet FDA-approved but have completed or are completing Phase 3 clinical trials
Local, licensed clinicians